newsfilter
← Latest News
Business Wire·

Alzamend Neuro Announces Additional Investment Under Its Investigational New Drug Application for AL001 for Dementia Related to Alzheimer's Pursuant to the Securities Purchase Agreement with Digital Power Lending

Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend") announced that Digital Power Lending, LLC ("DPL"), a wholly owned subsidiary of Ault Global Holdings, Inc. ("AGH") (NYSE:DPW), a diversified holding company, has made an additional investment in Alzamend,